Study on low sperm count by giving Kalnar Parpam Tablet

Phase 2

Not yet recruiting

• Conditions: Oligospermia,

• Registration Number: CTRI/2023/10/058832
• Lead Sponsor: Dr S Lalithakumari

Brief Summary

This is a Single arm Phras-1 Experimental study to determine the effectiveness of *Kalnar Parpam* in the management of *Vindhu Nattam* (Oligospermia) among outpatients attending ayothidoss pandithar hospital, national institute of siddhain 10 Male Patients**.** The study will be conducted among the adult patients with oligozoospermia having  sperm count below 15 million / ml, poor motility, Poor quantity and quality of seminal fluid who approaches to Ayothidoss Pandithar hospital, NIS, Chennai. Trial participants will be included based on Inclusion and Exclusion criteria. After enrolment trial drug *Kalnar Parpam tablet* will be given as 2 tablets twice a day with ghee or butter for 90 continues days. Outcome of the trial will be assessed through improvement in semen parameters such as sperm count, volume, viscosity both in quality and quantity will be assessed by semen analysis**.**

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-10-20
• Study Start: 2023-10-25

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Male
• Target Recruitment: 10

Inclusion Criteria

• Patient having abnormalities of Semen parameters Oligozoospermia (Sperm count < 15 million/ml).
• Poor motility, poor quantity and quality of seminal fluid 3.
• Willing to sign the consent form for enrollment in the study.

Exclusion Criteria

• Azoospermia 2.
• K/C/O testicular varicocele and hydrocele 3.
• K/C/O Filiariasis 4.
• History of Undescended testis 5.
• Genetic issues 6.
• Patients having chronic illness or tumors •Any anatomical defects.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in semen parameters such as sperm count, volume, viscosity both in quality and quantity, morphology will be assessed by semen analysis	90 days

Secondary Outcome Measures

Name	Time	Method
NA	NA

Trial Locations

Locations (1)

AYOTHIDOSS PANDITHAR HOSPITAL, NATIONAL INSTITUTE OF SIDDHA; 🇮🇳 Kancheepuram, TAMIL NADU, India

AYOTHIDOSS PANDITHAR HOSPITAL, NATIONAL INSTITUTE OF SIDDHA

🇮🇳Kancheepuram, TAMIL NADU, India

Dr S LALITHAKUMARI

Principal investigator

9994533518

dhanabalan1972@gmail.com